Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway

BACKGROUND: There are a lot of unmet needs in patients with triple-negative breast cancer (TNBC). Fenofibrate, a peroxisome proliferator-activated receptor alpha (PPAR-α) agonist, has been used for decades to treat hypertriglyceridaemia and mixed dyslipidaemia. Recent studies show that it might have...

Full description

Saved in:
Bibliographic Details
Main Authors: Li, Ting, Zhang, Qunling, Zhang, Jian, Yang, Gong, Shao, Zhimin, Luo, Jianmin, Fan, Minhao, Ni, Chen, Wu, Zhenhua, Hu, Xichun
Format: Artigo
Language:Inglês
Published: BioMed Central 2014
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4015735/
https://ncbi.nlm.nih.gov/pubmed/24529079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-14-96
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items